News | June 18, 2026
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
CEO Stéphane Bancel framed the changes as essential to scaling the business
CEO Stéphane Bancel framed the changes as essential to scaling the business
The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio
Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets
Hospital data reveals a sharp rise in consultations related to hormonal health, erectile dysfunction and male fertility, highlighting growing awareness among younger men.
Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias
Subscribe To Our Newsletter & Stay Updated
